From Yahoo Finance: 2025-05-09 10:32:00

JonesResearch lowered Lantheus (LNTH) price target to $120 from $134, citing competitive pressure on Pylarify and a 0.5% decrease in net sales. Despite near-term concerns, the firm maintains a Buy rating, expressing confidence in Lantheus’ radiopharmaceutical pipeline. The stock has faced negative pressure due to ongoing business reorganization and reduced fiscal 2025 earnings guidance. The firm expects improved margins post-acquisitions and divestitures, anticipating strong execution in the medium- to long-term. Analysts acknowledge potential challenges from emerging PSMA-PET competition but remain optimistic about Lantheus’ future prospects.



Read more at Yahoo Finance: Lantheus price target lowered to $120 from $134 at JonesResearch